|
14 Sep 2020 |
Gilead Sciences to Acquire Immunomedics
|
|
12 Sep 2020 |
Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia
|
|
10 Sep 2020 |
Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program
|
|
09 Sep 2020 |
Bayer collaborates with Recursion to strengthen digital drug discovery and advance new therapies for fibrotic diseases
|
|
08 Sep 2020 |
Exelixis and Catalent Enter into Collaboration, License, and Exclusive Option Agreement to Develop Antibody-Drug Conjugates Leveraging SMARTag® Bioconjugation Technology
|
|
08 Sep 2020 |
Exelixis and NBE-Therapeutics Enter Into Exclusive Collaboration and License Option Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
|
|
07 Sep 2020 |
Grifols to acquire Alkahest to enhance discovery research and development to identify innovative therapies for age-related diseases based upon an understanding of the human plasma proteome
|
|
04 Sep 2020 |
Kite and HiFiBiO Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia
|
|
02 Sep 2020 |
BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for Inflammatory Bowel Disease
|
|
02 Sep 2020 |
Orca Bio and Lyell Immunopharma Announce Research Partnership
|
|
02 Sep 2020 |
Sorrento Announces the Closing of Its Acquisition of SmartPharm to Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-Efficient and In Vivo Production of Antibody Therapeutics in Patients
|
|
01 Sep 2020 |
Boston Pharmaceuticals Licenses NASH Development Candidate from Novartis
|
|
01 Sep 2020 |
Elektrofi and LEO Pharma Enter Licensing Agreement for Development of High-Concentration, Low-Volume Formulations of Investigational Monoclonal Antibodies
|
|
01 Sep 2020 |
Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc. to profile signaling pathways of GPCRs across multiple diseases
|
|
01 Sep 2020 |
SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics
|
|
31 Aug 2020 |
Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science
|
|
31 Aug 2020 |
Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics
|
|
26 Aug 2020 |
ACADIA Pharmaceuticals Acquires CerSci Therapeutics, Adds Novel Pain Program to Portfolio
|
|
25 Aug 2020 |
AbbVie, Harvard University Form Research Alliance to Address Emergent Viral Diseases
|
|
25 Aug 2020 |
Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases
|
|
25 Aug 2020 |
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
|
|
24 Aug 2020 |
NantKwest and ImmunityBio Sign Collaboration Agreement for Joint Development, Manufacturing, Marketing, and Commercialization of COVID-19 Vaccine and Related Therapeutics
|
|
21 Aug 2020 |
Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies to Treat COVID-19 and Cancer Therapeutics
|
|
19 Aug 2020 |
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases
|
|
18 Aug 2020 |
LG Chem Life Sciences and TransThera Biosciences Announce License Agreement for Potential Treatment of NASH and Other Chronic Inflammatory Conditions
|
